Transferability of Economic Evaluations of Treatments for Advanced Melanoma.

ABSTRACT:

Background

Differing methodological requirements and decision-making criteria are recognised as barriers to transferability of cost-effectiveness analysis (CEA) across jurisdictions.

Objective

We assessed the generic and specific transferability of published CEAs of systemic treatments for advanced melanoma to the Irish setting.

Methods

CEAs of treatments for melanoma were identified by systematic review. Transferability to the Irish setting was assessed using the EUnetHTA transferability tool for Economic Evaluation. We present a narrative discussion comparing the differences in key parameter inputs and the likely impact of these differences on the model outcomes and the reimbursement recommendation. Transferability is considered within the context of the Irish cost-

SUBMITTER: Gorry C 

PROVIDER: S-EPMC7081651 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature